Table 1.

Cohorts in the trial

Cohort
N
B9E9FP, mg/m2
Interval 1, h
sCA, mg/m2
Interval 2, h
111In, mCi
90Y, mCi/m2
DOTA-biotin, mg/m2
A   3-5   160 ± 186Re 30 mCi   72   45   24   5   15   1.3  
B   3-5   160   48   45   24   5   15   1.3  
C   3-5   320 ± 186Re 30 mCi   48   45   24   5   15   1.3  
D
 		 3-5
 		 160
 		 48
 		 45
 		 24
 		 5
 		 15
 		 0.65
 
Cohort
N
B9E9FP, mg/m2
Interval 1, h
sCA, mg/m2
Interval 2, h
111In, mCi
90Y, mCi/m2
DOTA-biotin, mg/m2
A   3-5   160 ± 186Re 30 mCi   72   45   24   5   15   1.3  
B   3-5   160   48   45   24   5   15   1.3  
C   3-5   320 ± 186Re 30 mCi   48   45   24   5   15   1.3  
D
 		 3-5
 		 160
 		 48
 		 45
 		 24
 		 5
 		 15
 		 0.65
 

sCA indicates synthetic clearing agent.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal